T. Rowe Price Associates’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-598,200
| Closed | -$195M | – | 3071 |
|
|
2024
Q1 | $195M | Sell |
598,200
-186,769
| -24% | -$60.8M | 0.02% | 424 |
|
|
2023
Q4 | $150M | Sell |
784,969
-452,772
| -37% | -$86.3M | 0.02% | 467 |
|
|
2023
Q3 | $246M | Buy |
1,237,741
+146,691
| +13% | +$29.2M | 0.04% | 350 |
|
|
2023
Q2 | $311M | Sell |
1,091,050
-303,717
| -22% | -$86.7M | 0.04% | 318 |
|
|
2023
Q1 | $302M | Buy |
1,394,767
+382,374
| +38% | +$82.9M | 0.05% | 313 |
|
|
2022
Q4 | $208M | Sell |
1,012,393
-784,628
| -44% | -$161M | 0.03% | 372 |
|
|
2022
Q3 | $500M | Sell |
1,797,021
-1,417,657
| -44% | -$394M | 0.08% | 225 |
|
|
2022
Q2 | $615M | Buy |
3,214,678
+627,712
| +24% | +$120M | 0.08% | 248 |
|
|
2022
Q1 | $536M | Sell |
2,586,966
-490,286
| -16% | -$102M | 0.05% | 317 |
|
|
2021
Q4 | $549M | Sell |
3,077,252
-142,722
| -4% | -$25.5M | 0.05% | 336 |
|
|
2021
Q3 | $663M | Sell |
3,219,974
-76,720
| -2% | -$15.8M | 0.06% | 300 |
|
|
2021
Q2 | $625M | Sell |
3,296,694
-642,323
| -16% | -$122M | 0.06% | 306 |
|
|
2021
Q1 | $513M | Buy |
3,939,017
+1,458,245
| +59% | +$190M | 0.05% | 329 |
|
|
2020
Q4 | $257M | Buy |
2,480,772
+150,031
| +6% | +$15.6M | 0.03% | 459 |
|
|
2020
Q3 | $177M | Sell |
2,330,741
-243,105
| -9% | -$18.4M | 0.02% | 512 |
|
|
2020
Q2 | $122M | Sell |
2,573,846
-91,127
| -3% | -$4.32M | 0.02% | 580 |
|
|
2020
Q1 | $88.4M | Sell |
2,664,973
-1,365,237
| -34% | -$45.3M | 0.01% | 606 |
|
|
2019
Q4 | $177M | Buy |
4,030,210
+418,013
| +12% | +$18.4M | 0.02% | 507 |
|
|
2019
Q3 | $108M | Buy |
3,612,197
+1,554,422
| +76% | +$46.5M | 0.02% | 609 |
|
|
2019
Q2 | $114M | Buy |
2,057,775
+162,999
| +9% | +$9.04M | 0.02% | 610 |
|
|
2019
Q1 | $61.4M | Buy |
+1,894,776
| New | +$61.4M | 0.01% | 792 |
|